Fluorouracil, methyl-ccnu and vincristine in cancer of the colon
- 1 October 1976
- Vol. 38 (4), 1468-1470
- https://doi.org/10.1002/1097-0142(197610)38:4<1468::aid-cncr2820380403>3.0.co;2-k
Abstract
In a randomized study 91 patients with metastatic cancer of the colon were treated with either fluorouracil alone or a combination of fluorouracil, methyl-CCNU, and vincristine. Of those treated with the three-drug combination, 37% responded, and of those treated with fluorouracil alone, 22% responded. Median response duration for patients treated with the combination method was 5.0 months and for those with fluorouracil alone, 3.8 months. Toxic effects are also compared. From this study it is concluded that a three-drug regimen provides a definite advantage.This publication has 5 references indexed in Scilit:
- Integration of chemotherapy into combined modality treatment of solid tumors: II. Large bowel carcinomaCancer Treatment Reviews, 1974
- Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancerCancer, 1974
- Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinosideCancer, 1972
- Five Years Clinical Experience with 5-FluorouracilJAMA, 1962
- CLINICAL STUDIES WITH 5-FLUOROURACIL1958